Cargando…
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Metformin, the first drug chosen to be tested in a clinical trial aimed to target the biology of aging per se, has been clinically exploited for decades in the absence of a complete understanding of its therapeutic targets or chemical determinants. We here outline a systematic chemoinformatics appro...
Autores principales: | Cuyàs, Elisabet, Verdura, Sara, Llorach‐Pares, Laura, Fernández‐Arroyo, Salvador, Luciano‐Mateo, Fedra, Cabré, Noemí, Stursa, Jan, Werner, Lukas, Martin‐Castillo, Begoña, Viollet, Benoit, Neuzil, Jiri, Joven, Jorge, Nonell‐Canals, Alfons, Sanchez‐Martinez, Melchor, Menendez, Javier A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052472/ https://www.ncbi.nlm.nih.gov/pubmed/29740925 http://dx.doi.org/10.1111/acel.12772 |
Ejemplares similares
-
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
por: Cuyàs, Elisabet, et al.
Publicado: (2018) -
Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A
por: Cuyàs, Elisabet, et al.
Publicado: (2019) -
Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer’s Disease Therapeutic Agents
por: Llorach-Pares, Laura, et al.
Publicado: (2017) -
Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer’s Disease: A Computational Study
por: Llorach-Pares, Laura, et al.
Publicado: (2018) -
Computer-Aided Drug Design (CADD) to De-Orphanize Marine Molecules: Finding Potential Therapeutic Agents for Neurodegenerative and Cardiovascular Diseases
por: Llorach-Pares, Laura, et al.
Publicado: (2022)